bezafibrate has been researched along with Connective Tissue Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuhara, S; Kagawa, H; Nagahama, M; Nomura, S; Ozaki, Y | 1 |
| Dorić, M; Gligora, M | 1 |
2 other study(ies) available for bezafibrate and Connective Tissue Diseases
| Article | Year |
|---|---|
Effect of bezafibrate on soluble adhesion molecules and platelet activation markers in patients with connective tissue diseases and secondary hyperlipidemia.
Topics: Bezafibrate; Biomarkers; Blood Platelets; Cell Adhesion Molecules; Connective Tissue Diseases; Female; Flow Cytometry; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Platelet Activation; Solubility | 2001 |
Further possibilities of using aryloxycarbonic acid derivatives in clinical practice.
Topics: Anticholesteremic Agents; Bezafibrate; Clofibrate; Connective Tissue Diseases; Fenofibrate; Humans; Lymphocyte Activation; Phytohemagglutinins | 1991 |